Our assessment
NuuVim charges the same for an oral and an injectable version of each molecule, which is a genuinely useful thing to publish. The catch is the billing term. The four compounded options use monthly-equivalent prices billed in three-month plans, and the page sends a returning buyer to a column for the renewal rate that has no figure in it. Its own competitor comparison table sits right beside its prices, so read carefully which numbers are NuuVim's.
Four lanes, two prices, one billing term
Injectable and oral semaglutide carry the same figure. Injectable and oral tirzepatide carry the same higher one. Each is shown as a per-month rate and then, on the next line, as a total for a first three months on a three-month billing plan.
So the monthly number is a prepayment. What you are actually charged is the three-month total, and these compounded offers are not month-to-month.
The page sends a returning buyer to a "Current User" column for standard and renewal rates. That column carries no figure. You commit to three months without knowing what the fourth costs.
The table next to the prices is about other companies
Below its own plans, the site prints a comparison table of unnamed rivals with prices, membership-fee ticks and dose-pricing ticks. Those are not NuuVim's prices, and a disclaimer beneath the table says so.
It is easy to read a rival's number as NuuVim's, because they sit in the same block. Separate the figures on NuuVim’s own treatment cards from the rival figures in its comparison table.
The table does say one thing about NuuVim itself: its own row is ticked in the no-membership-fees column.
NuuVim's published pricing
Prices re-verified September 2026
| Medication | Price |
|---|---|
| MedicationSemaglutide (compounded) — all doses, one price | Price$79This requires a three-month prepayment: $79 a month, $237 total for the first 3 months, billed as a 3-month plan. The renewal rate after that isn't printed on the page. |
| MedicationSemaglutide (compounded-oral) — daily oral liquid | Price$79Listed as starting at $79 a month for new users, for the daily oral liquid semaglutide — billed on the same three-month plan as the injection. |
| MedicationTirzepatide (compounded) — all doses, one price | Price$133Listed as starting at $133 a month for new users, for the tirzepatide injection — billed on the same three-month plan. |
| MedicationTirzepatide (compounded-oral) — daily oral liquid | Price$133Listed as starting at $133 a month for new users, for the daily oral liquid tirzepatide. |
| MedicationSemaglutide (brand) — Ozempic | Price$1,498/moListed as starting at $1,498 a month for Ozempic, one injection a week. |
| MedicationTirzepatide (brand) — Zepbound | Price$1,892/moListed as starting at $1,892 a month for Zepbound, one injection a week. |
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
See NuuVim's current price →Who NuuVim suits
Good fit if
- Readers comparing an oral and an injectable price for both molecules.
- Buyers willing to take a three-month billing plan.
- People who want two brand-name lanes priced beside compounded ones.
Look elsewhere if
- Anyone who needs the renewal rate before committing.
- Buyers who want month-to-month billing.
- Readers who want a named pharmacy, clinician or service area.
- People who find a competitor table beside a price list confusing.
What stands out about NuuVim
Strengths
- Prices an oral and an injectable version of both molecules, all four on one page, at the same two figures
- States the billing plan beside the figure — three months, with the total printed — rather than only the per-month number
- Attaches a disclaimer to its own competitor comparison table saying the rival figures are its own research
- Names its operating company in both its privacy notice and its terms
- No FDA warning letter identified for this company in our September 2026 search
Trade-offs
- Every compounded figure is a three-month prepayment, and the page tells a returning buyer to look at a "Current User" column for the renewal rate that it never prints
- The homepage adds a per-week figure for "first treatments" that matches none of the four plan prices
- The comparison table includes competitor prices alongside its own offers. Check which provider and program each figure describes
- The corporate name in its copyright-agent block is a business-formation vendor, not the operator
- Names no compounding pharmacy, no prescribing clinician and no service-area list
How this review was verified
- All four compounded figures are three-month plans. The page states the billing term and prints the three-month total beside each per-month rate.
- Every figure in the comparison table belongs to another company, and NuuVim attributes them in a disclaimer beneath it.
- The business-formation vendor named in its copyright-agent block is a filing service, not the operator of this site.
- Checked the FDA's public warning-letter database: no letter found.
Where NuuVim ranks
NuuVim qualifies for 5 of the 6 boards on this site. A board only ranks the providers that meet its own condition, so a missing board means NuuVim does not publish what that board sorts on.
- Semaglutide — #210 of 334
- Tirzepatide — #202 of 319
- Cheapest Overall — #239 of 396
- Brand-Name Available — #82 of 88
- Oral — #72 of 108
Compare NuuVim directly
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
| Provider | Score | From/mo | Full review | Action |
|---|---|---|---|---|
| Belle Health | 10.0/10 | From/mo$109Advertised monthly equivalent for a twelve-month supply; not a verified monthly installment. Six-month rate $119, two-month rate $135, one-month rate $199. Confirm the upfront payment and refill schedule. | Full reviewRead the Belle Health review | Visit |
| Midi Health | 10.0/10 | From/mo$164for a 4-week supply, the lowest of four published dose tiers, including shipping | Full reviewRead the Midi Health review | Visit |
| altRx | 8.6/10 | From/mo$89/moadvertised monthly starting price for a multi-dose vial; confirm plan length and checkout total | Full reviewRead the altRx review | Visit |
Frequently asked questions
Are the prices monthly?
The compounded offers are shown per month but billed as a three-month plan, with the total printed. Confirm brand-name terms separately.
What is the renewal rate?
Not printed. The page points at a column for it that carries no figure.
Is there a membership fee?
Its own comparison row is ticked in a no-membership-fees column.
Are the other prices on the page its own?
No. They're competitor figures the seller supplies and disclaims.
Does it have an FDA warning letter?
No letter was found, checked.
Ready to compare directly?
NuuVim scores 4.3/10 on this site's rubric. Review the published prices and their conditions above, then confirm your total with the provider. Visiting its site does not commit you to treatment.
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
Visit NuuVim →